ATE501717T1 - Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms) - Google Patents
Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms)Info
- Publication number
- ATE501717T1 ATE501717T1 AT07291391T AT07291391T ATE501717T1 AT E501717 T1 ATE501717 T1 AT E501717T1 AT 07291391 T AT07291391 T AT 07291391T AT 07291391 T AT07291391 T AT 07291391T AT E501717 T1 ATE501717 T1 AT E501717T1
- Authority
- AT
- Austria
- Prior art keywords
- agomelatin
- medications
- sms
- treatment
- production
- Prior art date
Links
- 201000001388 Smith-Magenis syndrome Diseases 0.000 title 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Connection Of Batteries Or Terminals (AREA)
- General Preparation And Processing Of Foods (AREA)
- Primary Cells (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0610296A FR2908995B1 (fr) | 2006-11-24 | 2006-11-24 | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du syndrome de smith magenis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501717T1 true ATE501717T1 (de) | 2011-04-15 |
Family
ID=38229648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07291391T ATE501717T1 (de) | 2006-11-24 | 2007-11-23 | Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms) |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US20080132577A1 (de) |
| EP (1) | EP1929999B1 (de) |
| JP (1) | JP2008127395A (de) |
| KR (2) | KR20080047299A (de) |
| CN (1) | CN101194901A (de) |
| AR (1) | AR063896A1 (de) |
| AT (1) | ATE501717T1 (de) |
| AU (1) | AU2007234614B2 (de) |
| BR (1) | BRPI0704453A2 (de) |
| CA (1) | CA2610638C (de) |
| CL (1) | CL2007003396A1 (de) |
| CY (1) | CY1111430T1 (de) |
| DE (1) | DE602007013166D1 (de) |
| DK (1) | DK1929999T3 (de) |
| EA (1) | EA013471B1 (de) |
| ES (1) | ES2363252T3 (de) |
| FR (1) | FR2908995B1 (de) |
| GE (1) | GEP20094746B (de) |
| HR (1) | HRP20110370T1 (de) |
| JO (1) | JO2656B1 (de) |
| MA (1) | MA29523B1 (de) |
| ME (1) | ME01959B (de) |
| MX (1) | MX2007014199A (de) |
| MY (1) | MY145139A (de) |
| NO (1) | NO338951B1 (de) |
| NZ (1) | NZ563684A (de) |
| PE (1) | PE20081347A1 (de) |
| PL (1) | PL1929999T3 (de) |
| PT (1) | PT1929999E (de) |
| RS (1) | RS51676B (de) |
| SA (1) | SA07280635B1 (de) |
| SG (1) | SG143203A1 (de) |
| SI (1) | SI1929999T1 (de) |
| TW (1) | TWI370735B (de) |
| UA (1) | UA94042C2 (de) |
| UY (1) | UY30704A1 (de) |
| WO (1) | WO2008071870A2 (de) |
| ZA (1) | ZA200710103B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12012000132B1 (en) * | 2011-06-09 | 2014-10-20 | Servier Lab | New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them |
| FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| EP2810647A1 (de) * | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure |
| HUE036989T2 (hu) | 2013-06-06 | 2018-08-28 | Zentiva Ks | Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz |
| CN120078758A (zh) * | 2025-03-17 | 2025-06-03 | 南通大学附属医院 | 阿戈美拉汀在制备治疗干燥综合征药物中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1564202A (en) * | 1924-05-20 | 1925-12-08 | Christensen Jens Herman | Method of producing water-insoluble multicolored screens |
| FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
-
2006
- 2006-11-24 FR FR0610296A patent/FR2908995B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-01 ZA ZA200710103A patent/ZA200710103B/en unknown
- 2007-11-07 PE PE2007001528A patent/PE20081347A1/es not_active Application Discontinuation
- 2007-11-08 UY UY30704A patent/UY30704A1/es not_active Application Discontinuation
- 2007-11-13 MX MX2007014199A patent/MX2007014199A/es active IP Right Grant
- 2007-11-13 MY MYPI20071976A patent/MY145139A/en unknown
- 2007-11-19 MA MA30379A patent/MA29523B1/fr unknown
- 2007-11-21 US US11/986,501 patent/US20080132577A1/en not_active Abandoned
- 2007-11-22 JP JP2007302457A patent/JP2008127395A/ja active Pending
- 2007-11-22 JO JO2007487A patent/JO2656B1/en active
- 2007-11-22 AR ARP070105184A patent/AR063896A1/es unknown
- 2007-11-22 GE GEAP200710391A patent/GEP20094746B/en unknown
- 2007-11-22 AU AU2007234614A patent/AU2007234614B2/en not_active Ceased
- 2007-11-22 CL CL200703396A patent/CL2007003396A1/es unknown
- 2007-11-23 KR KR1020070120251A patent/KR20080047299A/ko not_active Ceased
- 2007-11-23 CA CA2610638A patent/CA2610638C/fr not_active Expired - Fee Related
- 2007-11-23 ME MEP-2011-219A patent/ME01959B/de unknown
- 2007-11-23 EP EP07291391A patent/EP1929999B1/de active Active
- 2007-11-23 DE DE602007013166T patent/DE602007013166D1/de active Active
- 2007-11-23 TW TW096144583A patent/TWI370735B/zh not_active IP Right Cessation
- 2007-11-23 WO PCT/FR2007/001926 patent/WO2008071870A2/fr not_active Ceased
- 2007-11-23 CN CNA2007103061420A patent/CN101194901A/zh active Pending
- 2007-11-23 PL PL07291391T patent/PL1929999T3/pl unknown
- 2007-11-23 BR BRPI0704453-4A patent/BRPI0704453A2/pt not_active Application Discontinuation
- 2007-11-23 SG SG200718042-5A patent/SG143203A1/en unknown
- 2007-11-23 RS RS20110157A patent/RS51676B/sr unknown
- 2007-11-23 PT PT07291391T patent/PT1929999E/pt unknown
- 2007-11-23 UA UAA200713021A patent/UA94042C2/ru unknown
- 2007-11-23 NO NO20075989A patent/NO338951B1/no not_active IP Right Cessation
- 2007-11-23 ES ES07291391T patent/ES2363252T3/es active Active
- 2007-11-23 AT AT07291391T patent/ATE501717T1/de active
- 2007-11-23 NZ NZ563684A patent/NZ563684A/en not_active IP Right Cessation
- 2007-11-23 EA EA200702318A patent/EA013471B1/ru not_active IP Right Cessation
- 2007-11-23 DK DK07291391.6T patent/DK1929999T3/da active
- 2007-11-23 SI SI200730595T patent/SI1929999T1/sl unknown
- 2007-11-24 SA SA07280635A patent/SA07280635B1/ar unknown
-
2011
- 2011-04-27 CY CY20111100416T patent/CY1111430T1/el unknown
- 2011-05-18 HR HR20110370T patent/HRP20110370T1/hr unknown
- 2011-07-06 KR KR1020110066825A patent/KR20110086673A/ko not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
| EP1981526A4 (de) | Adiponectin zur behandlung verschiedener erkrankungen | |
| ATE550329T1 (de) | Heterobicyclische sulfonamidderivate zur behandlung von diabetes | |
| BRPI0716210A2 (pt) | Métodos, composições e aparelhos para tratar feridas com pressões diferentes da atmosférica | |
| DE602006020327D1 (de) | 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen | |
| ATE532507T1 (de) | Neramexane zur behandlung von subakuten tinnitus | |
| EP2135858A4 (de) | Zusammensetzung zur behandlung von infektionserkrankungen | |
| ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| LT2478907T (lt) | Kompozicijos vėžiui gydyti | |
| EA200802111A1 (ru) | Имплантаты для лечения состояний, ассоциируемых с допамином | |
| EP2249765A4 (de) | Dapson zur behandlung von rosascea | |
| ATE419837T1 (de) | Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungen | |
| AT503967A3 (de) | Vorrichtung zur herstellung von formteilen | |
| DK1888471T3 (da) | Anaerobt rensningsanlæg | |
| ATE516805T1 (de) | Medikament zur behandlung von endometriose | |
| DE602007013166D1 (de) | Einsatz von Agomelatin zur Herstellung von Medikamenten zur Behandlung des Smith-Magenis-Syndroms (SMS) | |
| ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
| ATE496913T1 (de) | Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| FI20051207A0 (fi) | Selän hoitolaite | |
| DE602007008759D1 (de) | Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1929999 Country of ref document: EP |